Matches in Nanopublications for { ?s ?p "[Importantly, it also indicates that it is crucial to evaluate the levels of Apaf-1 and XIAP proteins in patient samples before using Smac peptide therapy in the treatment of human leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Importantly, it also indicates that it is crucial to evaluate the levels of Apaf-1 and XIAP proteins in patient samples before using Smac peptide therapy in the treatment of human leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_assertion description "[Importantly, it also indicates that it is crucial to evaluate the levels of Apaf-1 and XIAP proteins in patient samples before using Smac peptide therapy in the treatment of human leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_provenance.
- assertion description "[Importantly, it also indicates that it is crucial to evaluate the levels of Apaf-1 and XIAP proteins in patient samples before using Smac peptide therapy in the treatment of human leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_assertion description "[Importantly, it also indicates that it is crucial to evaluate the levels of Apaf-1 and XIAP proteins in patient samples before using Smac peptide therapy in the treatment of human leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240180.RAc0AUIQkhW70R2X9pIS8wd5rgtGFRITt8uvyca6O9N8o130_provenance.
- NP242410.RAcB7MprHZIFA8N-SW4Ahyfgt3Vpi4QAYNEL66l7sNdw8130_assertion description "[Importantly, it also indicates that it is crucial to evaluate the levels of Apaf-1 and XIAP proteins in patient samples before using Smac peptide therapy in the treatment of human leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242410.RAcB7MprHZIFA8N-SW4Ahyfgt3Vpi4QAYNEL66l7sNdw8130_provenance.
- NP387369.RAM5CrNNDYkHzCnJV6lN96XyD6VefILBdAVSSbWnD9w4c130_assertion description "[Importantly, it also indicates that it is crucial to evaluate the levels of Apaf-1 and XIAP proteins in patient samples before using Smac peptide therapy in the treatment of human leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387369.RAM5CrNNDYkHzCnJV6lN96XyD6VefILBdAVSSbWnD9w4c130_provenance.
- NP387368.RA03pUAdIZttbzdIoik4HPe-RMm8vek2-coT_lSg86vhs130_assertion description "[Importantly, it also indicates that it is crucial to evaluate the levels of Apaf-1 and XIAP proteins in patient samples before using Smac peptide therapy in the treatment of human leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387368.RA03pUAdIZttbzdIoik4HPe-RMm8vek2-coT_lSg86vhs130_provenance.